检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:吴兆芳[1] 于艳丽[1] 韩红梅[1] 王艳香[1] 任妍 李发贵[1] WU Zhaofang;YU Yanli;HAN Hongmei(Department of Endocrinology,People's Hospital of Huangdao,Qingdao 266400,China)
出 处:《中国糖尿病杂志》2022年第6期431-435,共5页Chinese Journal of Diabetes
基 金:山东省老年医学学会科技攻关计划项目(LKJGG2021Z014)。
摘 要:目的 探讨T2DM患者胰岛素抗体(Ins-Ab)水平与UACR的相关性。方法 选取2016年1月至2018年5月于青岛市黄岛区人民医院内分泌科住院的T2DM患者1225例,根据UACR水平分为正常白蛋白尿组(NAU,n=862)、微量白蛋白尿组(MAU,n=252)和大量白蛋白尿组(CAU,n=111),比较各组一般资料及Ins-Ab阳性率。结果 NAU、MAU、CAU组DM病程、SBP、UACR、hs-CRP、Ins-Ab和Ins-Ab阳性率依次升高(P<0.05)。Spearman相关分析显示,UACR与Ins-Ab呈正相关(P<0.05)。Logistic回归分析显示,校正DM病程、WHR、hs-CRP、TC、SBP、HbA1c等混杂因素后,Ins-Ab阳性是DKD的危险因素。结论 Ins-Ab水平与UACR密切相关,Ins-Ab阳性是DKD的危险因素。Objective To explore the relationship between the level of insulin antibody(Ins-Ab)and urinary albumin/creatinine ratio(UACR)in patients with type 2 diabetes mellitus(T2DM).Methods A total of 1225 T2DM patients hospitalized in The Department of Endocrinology,People’s Hospital of Huangdao were enrolled in this study from January 2016 to May 2018. All the participants were divided into three groups:normoalbuminuria group(NAU,n=862),microalbuminuria group(MAU,n=252)and macroalbuminuria group(CAU,n=111)according to the level of UACR. The general clinical characteristics and the Ins-Ab positive rate were compared among the three groups.ResultsThe duration of DM,SBP,UACR,hs-CRP,Ins-Ab and the positive rate of Ins-Ab increased gradually in NAU,MAU and CAU groups(P<0. 05). Spearman correlation analysis showed that Ins-Ab was positively correlated with UACR(P<0. 05). Logistic regression analysis showed that after adjusting duration of DM,WHR,hs-CRP,TC,SBP,HbA1c and other confounding factors,Ins-Ab positive was a risk factor for DKD.Conclusion Ins-Ab is closely related to UACR,and Ins-Ab positive is an independent risk factor for DKD.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:13.58.229.23